The Economic Times

October 22, 2003
   

Sami Labs gets patents for 3 active ingredients



SAMI Labs, a Bangalore based Rs 250 crore biotech firm, has been granted three patents for new active ingredients in the fields of dermatology and infective & geriatric ophthalmology. Muhammed Majeed, chairman & MD, Sami Labs, told ET that the patents will pave the way for a renewed focus on discovery and intellectual property.
The three patented active ingredients- Tetrahydrocurcuminoids (THC), Coleus oil and Zealutien- are expected to revolutionise the dermatology, infective and geriatric ophthalmology markets.

Tetrahydrocurcuminoids are the white curcuminoids converted from the yellow active ingredient in turmeric. The component has significant antioxidant application and UV protection. The process of conversion from yellow to white improves bio-availability and eliminates the staining properties of curcuminoids. The process of stabilisation of lutein improves the longevity of a drug and its preventive capabilities. The oil extracted from Coleus Forskohli has strong anti-microbial properties, especially in fighting gram positive infections and dental microbial activity.

The ingredients in nutraceuticals and cosmeceuticals formulations have a market size of Rs 20 crore. Sami plans to capture 5% of the market in the next three years.